Advances in the use of milk thistle (Silybum marianum). (Q36840433)

16 August 2017

1 reference

title

Advances in the use of milk thistle (Silybum marianum). (English)

1 reference

16 August 2017

0 references

Janice Post-White

1

1 reference

16 August 2017

Elena J Ladas

series ordinal

2

1 reference

16 August 2017

Kara M Kelly

series ordinal

3

1 reference

16 August 2017

language of work or name

1 reference

1 June 2007

1 reference

Integrative Cancer Therapies

16 August 2017

1 reference

16 August 2017

6

1 reference

16 August 2017

2

1 reference

16 August 2017

104-109

1 reference

Molecular Structure and Stereochemistry of Silybin A, Silybin B, Isosilybin A, and Isosilybin B, Isolated from Silybum marianum (Milk Thistle)

16 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301632

Clinical applications of Silybum marianum in oncology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301632

Chemotherapy of Amanita phalloides poisoning with intravenous silibinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301632

Mechanism for the protective effects of silymarin against carbon tetrachloride-induced lipid peroxidation and hepatotoxicity in mice. Evidence that silymarin acts both as an inhibitor of metabolic activation and as a chain-breaking antioxidant

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301632

Effect of silybin and its congeners on human liver microsomal cytochrome P450 activities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301632

Tissue distribution of silibinin, the major active constituent of silymarin, in mice and its association with enhancement of phase II enzymes: implications in cancer chemoprevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301632

Toward the definition of the mechanism of action of silymarin: activities related to cellular protection from toxic damage induced by chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301632

Inhibition of human carcinoma cell growth and DNA synthesis by silibinin, an active constituent of milk thistle: comparison with silymarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301632

Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: implications for prostate cancer intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301632

Silibinin sensitizes human prostate carcinoma DU145 cells to cisplatin- and carboplatin-induced growth inhibition and apoptotic death

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301632

Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301632

Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301632

Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301632

Long-term (12 months) treatment with an anti-oxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301632

Randomised double-blinded trial evaluating silymarin for chronic hepatitis C in an Egyptian village: study description and 12-month results

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301632

Two-year results of a randomised double-blinded trial evaluating silymarin for chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301632

Effects of Silybum marianum on serum hepatitis C virus RNA, alanine aminotransferase levels and well-being in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301632

Treatment of amatoxin poisoning: 20-year retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301632

Review of clinical trials evaluating safety and efficacy of milk thistle (Silybum marianum [L.] Gaertn.).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301632

Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301632

Aminotransferase levels and silymarin in de novo tacrine-treated patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301632

A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301632

Milk thistle: is there a role for its use as an adjunct therapy in patients with cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301632

Milk thistle for the treatment of liver disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301632

The use of silymarin in the treatment of liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301632

Evidence summaries and synthesis: necessary but insufficient approach for determining clinical practice of integrated medicine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301632

Randomized, double-blind, placebo-controlled crossover study in men with prostate cancer and rising PSA: effectiveness of a dietary supplement

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301632

SILYMARIN EFFECTS ON INTRACELLULAR CALCUIM AND CYTOTOXICITY: A STUDY IN PERFUSED RAT HEPATOCYTES AFTER OXIDATIVE STRESS INJURY

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1534735407301632

21 January 2018

Identifiers

DOI

10.1177/1534735407301632

1 reference

16 August 2017

1 reference